Adaptimmune Therapeutics PLC - ADR (OQ:ADAP)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for ADAP within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 28th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 26/24 Mar 26/24 EcoR1 Capital, LLC Indirect Ownership Ordinary Shares Form 3 : Initial Statement of Beneficial Ownership of Securities    
Mar 18/24 Mar 18/24 Piccina Cintia Direct Ownership Option to purchase Ordinary Shares A - Grant, award or other under Rule 16b-3(d) 1,130,832  
Mar 18/24 Mar 18/24 Piccina Cintia Direct Ownership Option to purchase Ordinary Shares A - Grant, award or other under Rule 16b-3(d) 5,088,864  
Jan 17/24 Jan 17/24 Rawcliffe Adrian Direct Ownership American Depositary Shares representing Ordinary Shares S - Open market or private sale -30,080 $0.673
Jan 17/24 Jan 17/24 Norry Elliot Direct Ownership American Depositary Shares representing Ordinary Shares S - Open market or private sale -12,967 $0.673
Jan 17/24 Jan 17/24 Norry Elliot Direct Ownership American Depositary Shares representing Ordinary Shares S - Open market or private sale -5,309 $0.673
Jan 17/24 Jan 17/24 Lunger John Direct Ownership American Depositary Shares representing Ordinary Shares S - Open market or private sale -12,805 $0.673
Jan 17/24 Jan 17/24 Lunger John Direct Ownership American Depositary Shares representing Ordinary Shares S - Open market or private sale -5,309 $0.673
Jan 17/24 Jan 17/24 Bertrand William C JR Direct Ownership American Depositary Shares representing Ordinary Shares S - Open market or private sale -13,599 $0.673
Jan 17/24 Jan 17/24 Bertrand William C JR Direct Ownership American Depositary Shares representing Ordinary Shares S - Open market or private sale -5,309 $0.673
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ADAP within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 28th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 26/24 Mar 26/24 EcoR1 Capital, LLC Indirect Ownership Ordinary Shares Form 3 : Initial Statement of Beneficial Ownership of Securities    
Mar 18/24 Mar 18/24 Piccina Cintia Direct Ownership Option to purchase Ordinary Shares A - Grant, award or other under Rule 16b-3(d) 1,130,832  
Mar 18/24 Mar 18/24 Piccina Cintia Direct Ownership Option to purchase Ordinary Shares A - Grant, award or other under Rule 16b-3(d) 5,088,864  
Jan 17/24 Jan 15/24 Behbahani Ali Direct Ownership Option to purchase Ordinary Shares A - Grant, award or other under Rule 16b-3(d) 40,950  
Jan 17/24 Jan 17/24 Rawcliffe Adrian Direct Ownership American Depositary Shares representing Ordinary Shares S - Open market or private sale -30,080 $0.673
Jan 17/24 Jan 16/24 Rawcliffe Adrian Direct Ownership American Depositary Shares representing Ordinary Shares S - Open market or private sale -9,304 $0.790
Jan 17/24 Jan 17/24 Norry Elliot Direct Ownership American Depositary Shares representing Ordinary Shares S - Open market or private sale -12,967 $0.673
Jan 17/24 Jan 17/24 Norry Elliot Direct Ownership American Depositary Shares representing Ordinary Shares S - Open market or private sale -5,309 $0.673
Jan 17/24 Jan 16/24 Norry Elliot Direct Ownership American Depositary Shares representing Ordinary Shares S - Open market or private sale -2,287 $0.790
Jan 17/24 Jan 17/24 Lunger John Direct Ownership American Depositary Shares representing Ordinary Shares S - Open market or private sale -12,805 $0.673
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $ADAP

  • No tweets found

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.